NO780644L - Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater - Google Patents

Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater

Info

Publication number
NO780644L
NO780644L NO780644A NO780644A NO780644L NO 780644 L NO780644 L NO 780644L NO 780644 A NO780644 A NO 780644A NO 780644 A NO780644 A NO 780644A NO 780644 L NO780644 L NO 780644L
Authority
NO
Norway
Prior art keywords
hydroxyethoxymethylguanine
derivatives
procedure
preparation
therapeutic active
Prior art date
Application number
NO780644A
Other languages
English (en)
Other versions
NO153260C (no
NO153260B (no
Inventor
Howard John Schaeffer
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO780644L publication Critical patent/NO780644L/no
Publication of NO153260B publication Critical patent/NO153260B/no
Publication of NO153260C publication Critical patent/NO153260C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
NO780644A 1977-02-24 1978-02-24 Analogifremgangsmaate for fremstilling av antiviralt virksomme 9-hydroksyetoksyguaninderivater NO153260C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77177877A 1977-02-24 1977-02-24
GB5390577 1977-12-24

Publications (3)

Publication Number Publication Date
NO780644L true NO780644L (no) 1978-08-25
NO153260B NO153260B (no) 1985-11-04
NO153260C NO153260C (no) 1986-02-12

Family

ID=26267373

Family Applications (1)

Application Number Title Priority Date Filing Date
NO780644A NO153260C (no) 1977-02-24 1978-02-24 Analogifremgangsmaate for fremstilling av antiviralt virksomme 9-hydroksyetoksyguaninderivater

Country Status (27)

Country Link
JP (1) JPS53108999A (no)
AR (2) AR219735A1 (no)
AT (1) AT353286B (no)
AU (1) AU521577B2 (no)
CA (1) CA1094062A (no)
CH (1) CH643858A5 (no)
DD (1) DD134098A5 (no)
DE (1) DE2808096A1 (no)
DK (1) DK147198C (no)
ES (2) ES467300A1 (no)
FI (1) FI68402C (no)
FR (1) FR2381781A1 (no)
GR (1) GR64404B (no)
HU (1) HU178808B (no)
IE (1) IE46210B1 (no)
IL (1) IL54130A0 (no)
IN (1) IN149483B (no)
IT (1) IT1105259B (no)
LU (1) LU79126A1 (no)
MC (1) MC1182A1 (no)
NL (1) NL7802111A (no)
NO (1) NO153260C (no)
NZ (1) NZ186555A (no)
PH (1) PH13996A (no)
PL (1) PL114474B1 (no)
PT (1) PT67706B (no)
SE (1) SE430507B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0015584A3 (de) * 1979-03-12 1980-12-10 Kailash Kumar Dr. Prof. Gauri Neue Nukleotide, Verfahren zu ihrer Herstellung und Arzneimittel
DE3490262T1 (de) * 1983-05-24 1985-11-28 Sri International, Menlo Park, Calif. Antivirus-Mittel
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
FR2733234B1 (fr) * 1995-04-21 1997-07-04 Centre Nat Rech Scient Derives de l'acyclovir comme agents antiviraux
WO1996033201A1 (en) * 1995-04-21 1996-10-24 Centre National De La Recherche Scientifique (Cnrs) Acyclovir derivatives as antiviral agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof

Also Published As

Publication number Publication date
DE2808096A1 (de) 1978-08-31
CA1094062A (en) 1981-01-20
FI68402B (fi) 1985-05-31
IT7848192A0 (it) 1978-02-24
PT67706A (en) 1978-03-01
SE430507B (sv) 1983-11-21
IL54130A0 (en) 1978-04-30
SE7802140L (sv) 1978-08-25
NO153260C (no) 1986-02-12
FI68402C (fi) 1985-09-10
IE780397L (en) 1978-08-24
FR2381781A1 (fr) 1978-09-22
LU79126A1 (fr) 1978-10-17
PL204885A1 (pl) 1979-04-23
AR218718A1 (es) 1980-06-30
MC1182A1 (fr) 1978-12-22
PL114474B1 (en) 1981-01-31
AU521577B2 (en) 1982-04-22
AT353286B (de) 1979-11-12
JPS53108999A (en) 1978-09-22
DK147198B (da) 1984-05-14
AU3356078A (en) 1979-08-30
NZ186555A (en) 1981-02-11
IE46210B1 (en) 1983-03-23
PT67706B (en) 1980-03-04
FR2381781B1 (no) 1980-04-25
NL7802111A (nl) 1978-08-28
IN149483B (no) 1981-12-26
HU178808B (en) 1982-06-28
CH643858A5 (en) 1984-06-29
ES470383A1 (es) 1979-09-16
NO153260B (no) 1985-11-04
AR219735A1 (es) 1980-09-15
PH13996A (en) 1980-11-28
ES467300A1 (es) 1978-10-16
DK85178A (da) 1978-08-25
ATA134678A (de) 1979-04-15
DD134098A5 (de) 1979-02-07
FI780626A (fi) 1978-08-25
IT1105259B (it) 1985-10-28
GR64404B (en) 1980-03-21
DE2808096C2 (no) 1988-02-18
DK147198C (da) 1984-11-12

Similar Documents

Publication Publication Date Title
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO782127L (no) Fremgangsmaate for fremstilling av fysiologisk aktive isoksazolo-pyridin-derivater
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO151240C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive nitroimidazoler
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO148957C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cyklopeptider
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO782756L (no) Fremgangsmaate for fremstilling av terapeutisk aktive antrakinonderivater
NO144848C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater
NO149065C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO780644L (no) Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
NO780743L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner
NO784325L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater
NO794318L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO152556C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner